These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31789705)

  • 1. Ocular myasthenia gravis: updates on an elusive target.
    Melson AT; McClelland CM; Lee MS
    Curr Opin Neurol; 2020 Feb; 33(1):55-61. PubMed ID: 31789705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
    Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
    Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of cortactin antibodies in myasthenia gravis.
    Illa I; Cortés-Vicente E; Martínez MÁ; Gallardo E
    Ann N Y Acad Sci; 2018 Jan; 1412(1):90-94. PubMed ID: 29068555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis.
    Marino M; Scuderi F; Samengo D; Saltelli G; Maiuri MT; Shen C; Mei L; Sabatelli M; Pani G; Antonini G; Evoli A; Bartoccioni E
    PLoS One; 2015; 10(8):e0135378. PubMed ID: 26284792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
    Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
    Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
    Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
    JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle autoantibodies in myasthenia gravis: beyond diagnosis?
    Meriggioli MN; Sanders DB
    Expert Rev Clin Immunol; 2012 Jul; 8(5):427-38. PubMed ID: 22882218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].
    Ohta R; Motomura M
    Rinsho Byori; 2014 Mar; 62(3):255-60. PubMed ID: 24800501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.
    Hurst RL; Gooch CL
    Curr Neurol Neurosci Rep; 2016 Jul; 16(7):61. PubMed ID: 27170368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autoantibodies in myasthenia gravis].
    Motomura M; Narita Masuda T
    Brain Nerve; 2013 Apr; 65(4):433-9. PubMed ID: 23568991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic use of autoantibodies in myasthenia gravis.
    Leite MI; Waters P; Vincent A
    Autoimmunity; 2010 Aug; 43(5-6):371-9. PubMed ID: 20380582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
    PLoS One; 2018; 13(3):e0193723. PubMed ID: 29518096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis.
    Vincent A; Leite MI
    Curr Opin Neurol; 2005 Oct; 18(5):519-25. PubMed ID: 16155434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody.
    Apinyawasisuk S; Chongpison Y; Thitisaksakul C; Jariyakosol S
    Am J Ophthalmol; 2020 Jan; 209():10-17. PubMed ID: 31562855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis.
    Cordts I; Bodart N; Hartmann K; Karagiorgou K; Tzartos JS; Mei L; Reimann J; Van Damme P; Rivner MH; Vigneron A; Weis J; Schulz JB; Tzartos SJ; Claeys KG
    J Neurol; 2017 Jun; 264(6):1193-1203. PubMed ID: 28516329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis.
    Guptill JT; Sanders DB
    Curr Opin Neurol; 2010 Oct; 23(5):530-5. PubMed ID: 20613516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bread-and-butter in diagnosis of myasthenia gravis.
    Chan AY; Liu DT
    Arch Neurol; 2005 Dec; 62(12):1939; author reply 1939-40. PubMed ID: 16344357
    [No Abstract]   [Full Text] [Related]  

  • 20. [Seronegative myasthenia gravis].
    Gajdos P
    Rev Neurol (Paris); 2004 Feb; 160(2):159-62. PubMed ID: 15034472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.